{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:25:18Z","timestamp":1791059118787,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.nmd.2008.05.004","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T06:05:04Z","timestamp":1214373904000},"page":"536-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Daily salbutamol in young patients with SMA type II"],"prefix":"10.1016","volume":"18","author":[{"given":"Marika","family":"Pane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Staccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pelliccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena S.","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cuttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Battini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Main","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Villanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2008.05.004_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1113\/jphysiol.2003.056770","article-title":"\u03b22-Agonist administration reverses muscle wasting and improves muscle function in aged rats","volume":"555","author":"Ryall","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.nmd.2008.05.004_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/cs0830615","article-title":"Salbutamol, a \u03b22-adrenoceptor agonist, increases skeletal muscle strength in young men","volume":"83","author":"Martineau","year":"1992","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.nmd.2008.05.004_bib3","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1249\/00005768-199511000-00002","article-title":"The effects of albuterol and isokinetic exercise on the quadriceps muscle group","volume":"27","author":"Caruso","year":"1995","journal-title":"Med Sci Sport Exer"},{"key":"10.1016\/j.nmd.2008.05.004_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0003-9993(95)80043-3","article-title":"Increased muscle strength in paralyzed patients after spinal cord injury: effect of \u03b2-adrenergic agonist","volume":"76","author":"Signorile","year":"1995","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2008.05.004_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.59.4.609","article-title":"Pilot trial of albuterol in spinal muscular atrophy","volume":"59","author":"Kinali","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.05.004_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2004-821173","article-title":"Pilot trial of salbutamol in central core and multi-minicore diseases","volume":"35","author":"Messina","year":"2004","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2008.05.004_bib7","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.50.5.1402","article-title":"The FSH-DY group. Open-label clinical trial of albuterol in facioscapulohumeral muscular dystrophy","volume":"50","author":"Kissel","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.05.004_bib8","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1212\/WNL.57.8.1434","article-title":"Randomised, double-bind, placebo-controlled trial of albuterol in facio-scapulohumeral dystrophy","volume":"57","author":"Kissel","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.05.004_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting (26\u201328 June 92, Bonn, Germany)","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2008.05.004_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","article-title":"The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation","volume":"7","author":"Main","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2008.05.004_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nmd.2005.11.010","article-title":"Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study","volume":"16","author":"Mercuri","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2008.05.004_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","article-title":"Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy","volume":"68","author":"Mercuri","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.05.004_bib13","unstructured":"StataCorp.2005. Stata statistical software: Release 9.0. College Station, TX: StataCorp."},{"key":"10.1016\/j.nmd.2008.05.004_bib14","series-title":"Nonparametric statistics for the behavioural sciences","author":"Siegel","year":"1988"},{"key":"10.1016\/j.nmd.2008.05.004_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nmd.2004.04.004","article-title":"Concerns about the design of clinical trials for spinal muscular atrophy","volume":"14","author":"Crawford","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2008.05.004_bib16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy","volume":"52","author":"Zerres","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2008.05.004_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.10455","article-title":"Riluzole attenuates spinal muscular atrophy disease progression in a mouse model","volume":"28","author":"Haddad","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2008.05.004_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<521::AID-MUS10>3.0.CO;2-8","article-title":"Clenbuterol reduces degeneration of exercised or aged dystrophic (mdx) muscle","volume":"23","author":"Zeman","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2008.05.004_bib19","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1152\/japplphysiol.01081.2003","article-title":"\u03b22-Adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle following injury","volume":"96","author":"Beitzel","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nmd.2008.05.004_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jmg.2007.051177","article-title":"Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells","volume":"45","author":"Angelozzi","year":"2008","journal-title":"J Med Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089660800134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089660800134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:56:13Z","timestamp":1760774173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089660800134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S096089660800134X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2008.05.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daily salbutamol in young patients with SMA type II","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2008.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}